Profil
Lyman Max Lyon is the founder of MediQuest Therapeutics, Inc. which was founded in 1994.
He was the Chief Executive Officer of FiatLux Imaging, Inc. from 2010 to 2012.
He was also the President, Chief Executive & Financial Officer of Theriva Biologics, Inc. in 2010.
Ehemalige bekannte Positionen von Lyman Max Lyon
| Unternehmen | Position | Ende |
|---|---|---|
FiatLux Imaging, Inc.
 FiatLux Imaging, Inc. Packaged SoftwareTechnology Services FiatLux Imaging, Inc. develops and commercializes medical imaging software applications. It offers 3D advanced visualization and analysis for MRI and CT and digital radiography for use by neurosurgeons, cardiologists, orthopedists, radiologists and other image dependent providers. The company was founded in April 2007 by Mary Frances Feider, John Pella and Quentin Dewolf and is headquartered in Redmond, WA. | Präsident | 01.01.2012 |
| THERIVA BIOLOGICS, INC. | Finanzdirektor/CFO | 06.02.2010 |
MediQuest Therapeutics, Inc.
 MediQuest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MediQuest Therapeutics, Inc. developed drugs for the treatment of inflammatory skin diseases and conditions. Its lead product candidate, Vascana, is for the prevention and treatment of Raynaud’s Disease and Phenomenon that targets large, underserved markets and utilizes the unique benefits of its TAM delivery technology to address unmet patient needs. The company was founded in 1994 by Dennis E. Schwartz and Lyman Max Lyon Jr. and was headquartered in Seattle, WA. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| THERIVA BIOLOGICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
MediQuest Therapeutics, Inc.
MediQuest Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology MediQuest Therapeutics, Inc. developed drugs for the treatment of inflammatory skin diseases and conditions. Its lead product candidate, Vascana, is for the prevention and treatment of Raynaud’s Disease and Phenomenon that targets large, underserved markets and utilizes the unique benefits of its TAM delivery technology to address unmet patient needs. The company was founded in 1994 by Dennis E. Schwartz and Lyman Max Lyon Jr. and was headquartered in Seattle, WA. | Health Technology |
FiatLux Imaging, Inc.
FiatLux Imaging, Inc. Packaged SoftwareTechnology Services FiatLux Imaging, Inc. develops and commercializes medical imaging software applications. It offers 3D advanced visualization and analysis for MRI and CT and digital radiography for use by neurosurgeons, cardiologists, orthopedists, radiologists and other image dependent providers. The company was founded in April 2007 by Mary Frances Feider, John Pella and Quentin Dewolf and is headquartered in Redmond, WA. | Technology Services |
